🍁weight-loss.ca

Wegovy vs. Ozempic: What's Actually Different in Canada

Wegovy and Ozempic cause constant confusion because they're the same drug — semaglutide, made by Novo Nordisk — sold under two brand names for two different approved purposes. Understanding the real difference (dose, approval, price) helps you have a more informed conversation with your doctor and avoid overpaying for a prescription that doesn't match your situation.

Quick Verdict

Wegovy and Ozempic are the same drug — semaglutide, same manufacturer. Wegovy is approved for weight management at a higher 2.4mg dose; Ozempic tops out at 1mg for diabetes. Wegovy loses more weight but costs more; Ozempic's generic is cheaper.

Overall Winner: Depends on goal

Wegovy wins on maximum weight loss and on-label legitimacy for that purpose. Ozempic — particularly generic semaglutide — wins on cost and availability. Neither is a universal winner; the right choice depends on your dose needs and budget.

Head-to-Head Comparison

FeatureWegovyOzempic
Active ingredientSemaglutideSemaglutide (same drug)
ManufacturerNovo NordiskNovo Nordisk
Maximum dose2.4mg weekly1mg weekly (2mg in some markets)
Health Canada approval2021 — chronic weight management2018 — type 2 diabetes
Average weight loss (trials)15–22%10–15%
Generic availableNoYes — ~$114/month
Monthly cost (brand)$300–400+$250–350
Provincial coverageLimited, even though on-labelWidely covered for T2D

Category Breakdown

Weight loss effectiveness

The 2.4mg dose produces 15–22% average body weight loss versus 10–15% for Ozempic's 1mg maximum dose — a direct result of the higher, weight-management-specific dosing.

Wegovy

Cost (out of pocket)

Generic semaglutide at ~$114/month is less than half the cost of Wegovy, which has no generic equivalent at its higher dose.

Ozempic

On-label legitimacy for weight loss

Wegovy is the only one of the two Health Canada-approved specifically for weight management, which can matter for certain insurance reimbursement or prior-authorization processes.

Wegovy

Pharmacy availability

8 years of Canadian distribution plus two generic manufacturers gives Ozempic/generic semaglutide the most consistent stock nationwide.

Ozempic

Drug plan coverage

Because it's approved for type 2 diabetes, Ozempic is on far more provincial and private formularies than Wegovy, even though Wegovy is technically the on-label weight-loss product.

Ozempic

Overall Winner

Depends on goal

Wegovy wins on maximum weight loss and on-label legitimacy for that purpose. Ozempic — particularly generic semaglutide — wins on cost and availability. Neither is a universal winner; the right choice depends on your dose needs and budget.

In-Depth Look

Wegovy

Semaglutide at the higher, weight-loss-specific dose

8.0

Wegovy is semaglutide dosed up to 2.4mg weekly, Health Canada-approved since 2021 specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. It's the only semaglutide product with an on-label weight-loss indication in Canada, which matters for some insurance approval processes.

Pros

  • On-label for weight management — not an off-label use like Ozempic for weight loss
  • Highest average weight loss of the two options: 15–22% of body weight at 2.4mg
  • Purpose-built dose titration schedule for weight management specifically
  • Some private insurers require on-label indication for any coverage consideration

Cons

  • $300–400+/month out of pocket — more expensive than generic semaglutide
  • Limited provincial drug plan coverage even though it's on-label for weight loss
  • No generic version — semaglutide generics currently only match the lower Ozempic-equivalent doses
  • Less pharmacy stock consistency than Ozempic/generic semaglutide

Best for: Canadians who want the maximum semaglutide dose specifically approved for weight loss, and whose insurer requires an on-label prescription for any possible reimbursement consideration.

Cost: $300–400/month self-pay; limited coverage even under private plans.

Canada availability: Available at major pharmacy chains and telehealth providers across Canada, though less consistently stocked than Ozempic.

Ozempic

Semaglutide at diabetes doses — cheaper, and now generic

8.0

Ozempic is semaglutide dosed up to 1mg weekly, Health Canada-approved for type 2 diabetes management since 2018 and widely prescribed off-label for weight loss. Since May 2026, a bioequivalent generic (Apo-Semaglutide) is available at Ozempic's dose strengths for roughly $114/month.

Pros

  • Generic semaglutide available from ~$114/month — the cheapest way to access this drug class
  • Widest pharmacy availability and longest Canadian track record (since 2018)
  • Better provincial drug plan coverage, since it's on-label for type 2 diabetes
  • Still produces meaningful weight loss (10–15% average) for many patients

Cons

  • Off-label for weight loss — some insurers won't consider coverage for this use
  • Lower maximum dose than Wegovy, which caps average weight loss below Wegovy's results
  • Brand-name Ozempic (if the generic isn't stocked) still costs $250–350/month

Best for: Canadians focused on cost, those with type 2 diabetes who also want weight loss benefit, and anyone comfortable with an off-label weight-loss prescription.

Cost: Generic semaglutide ~$114/month; brand-name $250–350/month.

Canada availability: Widely available across Canada; generic now stocked at all major pharmacy chains.

Which Is Right for You?

Choose Wegovy if you:

  • You want the maximum approved semaglutide dose for weight loss specifically
  • Your insurer requires an on-label indication to even consider partial coverage
  • You've plateaued at Ozempic's 1mg dose and want to go higher
  • Cost is not the primary constraint

Choose Ozempic if you:

  • You want the lowest cost via generic semaglutide
  • You have type 2 diabetes and want a drug plan that's more likely to cover it
  • You're comfortable with an off-label weight-loss prescription
  • You want the most widely available option at your local pharmacy

🍁 Canadian Availability

The Wegovy vs. Ozempic confusion is common because they're identical molecules from the same manufacturer, differing only in maximum approved dose and labelled indication. Health Canada's separate approvals mean provincial drug plans often treat them very differently for coverage purposes — Ozempic is far more likely to be reimbursed because diabetes coverage is more established than obesity-medication coverage across Canadian formularies. With generic semaglutide now available at Ozempic's dose strengths, many Canadians are choosing the cheaper off-label route unless they specifically need Wegovy's higher dose.

Frequently Asked Questions

Essentially, yes. Both are semaglutide made by Novo Nordisk. Wegovy is approved at doses up to 2.4mg specifically for weight management, while Ozempic tops out at 1mg and is approved for type 2 diabetes. The drug itself is identical — only the dose and approved indication differ.

See Live Semaglutide Pricing Across Canada

Compare current prices for Wegovy, Ozempic, and generic semaglutide at 15+ Canadian pharmacies and telehealth providers.

Information on this page is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any weight loss program or changing medications.